Literature DB >> 24990860

Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure.

Emily E Noble1, Charles J Billington2, Catherine M Kotz3, ChuanFeng Wang4.   

Abstract

Central oxytocin reduces food intake and increases energy expenditure. The ventromedial hypothalamic nucleus (VMN) is associated with energy balance and contains a high density of oxytocin receptors. We hypothesized that oxytocin in the VMN is a negative regulator of energy balance acting to reduce feeding and increase energy expenditure. To test this idea, oxytocin or vehicle was injected directly into the VMN of Sprague-Dawley rats during fasted and nonfasted conditions. Energy expenditure (via indirect calorimetry) and spontaneous physical activity (SPA) were recorded simultaneously. Animals were also exposed to a conditioned taste aversion test, to determine whether oxytocin's effects on food intake were associated with malaise. When food was available during testing, oxytocin-induced elevations in energy expenditure lasted for 1 h, after which overall energy expenditure was reduced. In the absence of food during the testing period, oxytocin similarly increased energy expenditure during the first hour, but differences in 12-h energy expenditure were eliminated, implying that the differences may have been due to the thermic effects of feeding (digestion, absorption, and metabolic processing). Oxytocin acutely elevated SPA and reduced feeding at doses that did not cause a conditioned taste aversion during both the fed and fasted states. Together, these data suggest that oxytocin in the VMN promotes satiety and acutely elevates energy expenditure and SPA and implicates the VMN as a relevant site for the antiobesity effects of oxytocin.

Entities:  

Keywords:  energy expenditure; feeding; obesity; oxytocin; ventromedial hypothalamus

Mesh:

Substances:

Year:  2014        PMID: 24990860      PMCID: PMC4166752          DOI: 10.1152/ajpregu.00118.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  64 in total

1.  Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake.

Authors:  B R Olson; M D Drutarosky; E M Stricker; J G Verbalis
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

2.  Effects of central oxytocin administration on intraoral intake of glucose in deprived and nondeprived rats.

Authors:  C M Lokrantz; K Uvnäs-Moberg; J M Kaplan
Journal:  Physiol Behav       Date:  1997-08

3.  Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity.

Authors:  C Nicholson
Journal:  Brain Res       Date:  1985-05-06       Impact factor: 3.252

4.  Reduced sympathetic nervous system activity in rats with ventromedial hypothalamic lesions.

Authors:  J G Vander Tuig; A W Knehans; D R Romsos
Journal:  Life Sci       Date:  1982-03-15       Impact factor: 5.037

5.  Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.

Authors:  Silvana Gaetani; Fariba Oveisi; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

6.  The hypothalamic-neurohypophysial system of the rat: localization and quantitation of neurophysin by light microscopic immunocytochemistry in normal rats and in Brattleboro rats deficient in vasopressin and a neurophysin.

Authors:  H W Sokol; E A Zimmerman; W H Sawyer; A G Robinson
Journal:  Endocrinology       Date:  1976-05       Impact factor: 4.736

7.  The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.

Authors:  Silvana Gaetani; Jin Fu; Tommaso Cassano; Pasqua Dipasquale; Adele Romano; Laura Righetti; Silvia Cianci; Leonardo Laconca; Elisa Giannini; Sergio Scaccianoce; Jérôme Mairesse; Vincenzo Cuomo; Daniele Piomelli
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

8.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

9.  Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass.

Authors:  Yuko Maejima; Yusaku Iwasaki; Yui Yamahara; Misato Kodaira; Udval Sedbazar; Toshihiko Yada
Journal:  Aging (Albany NY)       Date:  2011-12       Impact factor: 5.682

10.  Leptin activates oxytocin neurons of the hypothalamic paraventricular nucleus in both control and diet-induced obese rodents.

Authors:  Mario Perello; Jesica Raingo
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

View more
  31 in total

1.  Medial nucleus tractus solitarius oxytocin receptor signaling and food intake control: the role of gastrointestinal satiation signal processing.

Authors:  Zhi Yi Ong; Amber L Alhadeff; Harvey J Grill
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-04       Impact factor: 3.619

Review 2.  Hyperpalatability and the Generation of Obesity: Roles of Environment, Stress Exposure and Individual Difference.

Authors:  Sarah-Jane Leigh; Frances Lee; Margaret J Morris
Journal:  Curr Obes Rep       Date:  2018-03

3.  Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females.

Authors:  Anna Aulinas; Reitumetse L Pulumo; Elisa Asanza; Christopher J Mancuso; Meghan Slattery; Christiane Tolley; Franziska Plessow; Jennifer J Thomas; Kamryn T Eddy; Karen K Miller; Anne Klibanski; Madhusmita Misra; Elizabeth A Lawson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

4.  Oxytocin decreases sweet taste sensitivity in mice.

Authors:  Michael S Sinclair; Isabel Perea-Martinez; Marianne Abouyared; Steven J St John; Nirupa Chaudhari
Journal:  Physiol Behav       Date:  2014-12-30

5.  Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats.

Authors:  Zachary S Roberts; Tami Wolden-Hanson; Miles E Matsen; Vitaly Ryu; Cheryl H Vaughan; James L Graham; Peter J Havel; Daniel W Chukri; Michael W Schwartz; Gregory J Morton; James E Blevins
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-26       Impact factor: 3.619

6.  Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

Authors:  Sara M Freeman; Julie Ngo; Bhavdeep Singh; Megan Masnaghetti; Karen L Bales; James E Blevins
Journal:  Neuroscience       Date:  2018-07-31       Impact factor: 3.590

7.  Intranasal oxytocin reduces weight gain in diet-induced obese prairie voles.

Authors:  Adele M Seelke; Maya A Rhine; Konterri Khun; Amira N Shweyk; Alexandria M Scott; Jessica M Bond; James L Graham; Peter J Havel; Tami Wolden-Hanson; Karen L Bales; James E Blevins
Journal:  Physiol Behav       Date:  2018-08-23

8.  Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.

Authors:  Jeff A Beeler; Rudolf P Faust; Susie Turkson; Honggang Ye; Xiaoxi Zhuang
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

9.  Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization.

Authors:  James E Blevins; Benjamin W Thompson; Vishwanath T Anekonda; Jacqueline M Ho; James L Graham; Zachary S Roberts; Bang H Hwang; Kayoko Ogimoto; Tami Wolden-Hanson; Jarrell Nelson; Karl J Kaiyala; Peter J Havel; Karen L Bales; Gregory J Morton; Michael W Schwartz; Denis G Baskin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-20       Impact factor: 3.619

Review 10.  A Systematic Review and Quantitative Meta-Analysis of Oxytocin's Effects on Feeding.

Authors:  Monica Leslie; Paulo Silva; Yannis Paloyelis; James Blevins; Janet Treasure
Journal:  J Neuroendocrinol       Date:  2018-02-26       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.